Mark Wunderlich

18PUBLICATIONS
190CO-AUTHORS
Gene and molecular therapyHaematological tumoursMolecular medicineRegenerative medicine (incl. stem cells)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 05, 2026
Targeting the METTL1/m7G axis as a therapeutic strategy in myeloid leukemia.

|May 05, 2026
Combining menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia.

|Dec 06, 2025
Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia.

Ke Wang, Shayan Saniei, Nikita Poddar

|Nov 14, 2025
Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation.

Tianyi Ling, Cristiana O'Brien, Jonathan R St-Germain

|Aug 01, 2025
ALKBH1 Drives Tumorigenesis and Drug Resistance via tRNA-decoding Reprogramming and Codon-biased Translation.

Chao Shen, Yuan Che, Keren Zhou

|Dec 20, 2024
Fusion-specific chromatin profiles mediate transcriptional heterogeneity in MLL-rearranged acute lymphoblastic leukemia.

Shan Lin, Michael Kotliar, Sushmitha Vallabh

Pageof 3

Frequent Collaborators

3 joint publications

Kenneth D Greis

3 joint publications

Chiharu Ishikawa

3 joint publications

Julie A Reisz

3 joint publications

Shan Lin